Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Incidence of Hypersensitivity Reactions During Hemodialysis.

Esteras R, Martín-Navarro J, Ledesma G, Fernández-Prado R, Carreño G, Cintra M, Cidraque I, Sanz I, Tarragón B, Alexandru S, Milla M, Astudillo E, Sánchez E, Mas S, Tejeiro RD, Ortiz A, Sánchez R, González-Parra E.

Kidney Blood Press Res. 2018 Sep 20;43(5):1472-1478. doi: 10.1159/000493662. [Epub ahead of print]

2.

Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma.

Azpiazu D, González-Parra E, Egido J, Villa-Bellosta R.

Sci Rep. 2018 Jul 23;8(1):11089. doi: 10.1038/s41598-018-29432-4.

3.

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Toxins (Basel). 2018 Jul 19;10(7). pii: E300. doi: 10.3390/toxins10070300. Review.

4.

Position statement for the management of comorbidities in psoriasis.

Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, González-Parra E, Jodar E, Joven B, Lázaro P, Olveira A, Quintero J, Rivera R.

J Eur Acad Dermatol Venereol. 2018 Jul 10. doi: 10.1111/jdv.15177. [Epub ahead of print]

PMID:
29992631
5.

Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration.

Mas S, Bosch-Panadero E, Abaigar P, Camarero V, Mahillo I, Civantos E, Sanchez-Ospina D, Ruiz-Priego A, Egido J, Ortiz A, González-Parra E.

PLoS One. 2018 Mar 12;13(3):e0193288. doi: 10.1371/journal.pone.0193288. eCollection 2018.

6.

Bisphenol A is an exogenous toxin that promotes mitochondrial injury and death in tubular cells.

Bosch-Panadero E, Mas S, Civantos E, Abaigar P, Camarero V, Ruiz-Priego A, Ortiz A, Egido J, González-Parra E.

Environ Toxicol. 2018 Mar;33(3):325-332. doi: 10.1002/tox.22519. Epub 2017 Dec 7.

PMID:
29214717
7.

Role of pyrophosphate in vascular calcification in chronic kidney disease.

Azpiazu D, Gonzalo S, González-Parra E, Egido J, Villa-Bellosta R.

Nefrologia. 2018 May - Jun;38(3):250-257. doi: 10.1016/j.nefro.2017.07.005. Epub 2017 Nov 11. English, Spanish.

8.

Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification.

Azpiazu D, González-Parra E, Ortiz A, Egido J, Villa-Bellosta R.

PLoS One. 2017 Aug 23;12(8):e0183730. doi: 10.1371/journal.pone.0183730. eCollection 2017.

9.

Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.

Aceña A, Franco-Peláez JA, Gutierrez-Landaluce C, Pello AM, Cristóbal C, Tarín N, Huelmos A, Carda R, Martín-Mariscal ML, Alonso J, González-Parra E, González-Casaus ML, Lorenzo Ó, López Bescos L, Egido J, Tuñón J.

Nutr Metab Cardiovasc Dis. 2017 Sep;27(9):762-767. doi: 10.1016/j.numecd.2017.06.006. Epub 2017 Jun 15.

PMID:
28803689
10.

Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.

Bonanad C, González-Parra E, Rivera R, Carrascosa JM, Daudén E, Olveira A, Botella-Estrada R.

Actas Dermosifiliogr. 2017 Nov;108(9):800-808. doi: 10.1016/j.ad.2016.12.023. Epub 2017 Jun 11. Review. English, Spanish.

PMID:
28610662
11.

Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.

Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Nutrients. 2017 May 12;9(5). pii: E489. doi: 10.3390/nu9050489. Review.

12.

Atrasentan for the treatment of diabetic nephropathy.

Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C.

Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Review.

PMID:
28468519
13.

Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients.

Rodríguez-Osorio L, de la Piedra C, Rubert M, Martín-Fernández M, González Casaus ML, Gracia-Iguacel C, Egido J, Villa-Bellosta R, González Parra E.

Nefrologia. 2017 Jul - Aug;37(4):389-396. doi: 10.1016/j.nefro.2016.11.021. Epub 2017 Apr 14. English, Spanish.

14.

The importance of bisphenol A, an uraemic toxin from exogenous sources, in haemodialysis patients.

Mas S, Egido J, González-Parra E; en representación del Grupo de Análisis del Papel del Bisfenol A en el Paciente en Hemodiálisis.

Nefrologia. 2017 May - Jun;37(3):229-234. doi: 10.1016/j.nefro.2017.01.011. Epub 2017 Apr 6. English, Spanish. No abstract available.

15.

Eculizumab in secondary atypical haemolytic uraemic syndrome.

Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.

Nephrol Dial Transplant. 2017 Mar 1;32(3):466-474. doi: 10.1093/ndt/gfw453.

16.

A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients.

Villa-Bellosta R, Rodriguez-Osorio L, Mas S, Abadi Y, Rubert M, de la Piedra C, Gracia-Iguacel C, Mahillo I, Ortiz A, Egido J, González-Parra E.

PLoS One. 2017 Mar 24;12(3):e0173831. doi: 10.1371/journal.pone.0173831. eCollection 2017.

17.

Gut microbiota in chronic kidney disease.

Cigarran Guldris S, González Parra E, Cases Amenós A.

Nefrologia. 2017 Jan - Feb;37(1):9-19. doi: 10.1016/j.nefro.2016.05.008. Epub 2016 Aug 21. Review. English, Spanish.

18.

Kidney Disease and Psoriasis. A New Comorbidity?

González-Parra E, Daudén E, Carrascosa JM, Olveira A, Botella R, Bonanad C, Rivera R; en representación del Grupo de Trabajo en Inflamación Sistémica en Psoriasis.

Actas Dermosifiliogr. 2016 Dec;107(10):823-829. doi: 10.1016/j.ad.2016.05.009. Epub 2016 Aug 3. English, Spanish.

PMID:
27497509
19.

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.

Tuñón J, González-Hernández I, Llanos-Jiménez L, Alonso-Martín J, Escudier-Villa JM, Tarín N, Cristóbal C, Sanz P, Pello AM, Aceña Á, Carda R, Orejas M, Tomás M, Beltrán P, Calero Rueda M, Marcos E, Serrano-Antolín JM, Gutiérrez-Landaluce C, Jiménez R, Cabezudo J, Curcio A, Peces-Barba G, González-Parra E, Muñoz-Siscart R, González-Casaus ML, Lorenzo A, Huelmos A, Goicolea J, Ibáñez B, Hernández G, Alonso-Pulpón LM, Farré J, Lorenzo Ó, Mahíllo-Fernández I, Egido J.

BMJ Open. 2016 Aug 5;6(8):e011287. doi: 10.1136/bmjopen-2016-011287.

20.

Alkalosis and Dialytic Clearance of Phosphate Increases Phosphatase Activity: A Hidden Consequence of Hemodialysis.

Villa-Bellosta R, González-Parra E, Egido J.

PLoS One. 2016 Jul 25;11(7):e0159858. doi: 10.1371/journal.pone.0159858. eCollection 2016.

Supplemental Content

Loading ...
Support Center